Repligen Corporation
RGEN Healthcare Medical Instruments & Supplies
Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.
- Revenue
- +10.9%
- EPS
- −351.9%
- Free cash flow
- −11.5%
- Total debt
- +3.28%
Quarter to September 2026, against a year earlier
Follow RGEN
Alert me
Repligen Corporation (RGEN) Operating cash flow
Repligen Corporation's operating cash flow for fiscal 2025 was $117.4M, down 33.1% from $175.4M in fiscal 2024. Over the twelve months to 30 September 2026 it was $129.9M. Over the past ten years it has ranged from $7.5M (fiscal 2016) to $175.4M (fiscal 2024); the current reading is higher than 73% of that period. Repligen Corporation ranks 20th of 51 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $117.4M | (33.06%) |
| FY2024 | $175.4M | 53.97% |
| FY2023 | $113.9M | (33.80%) |
| FY2022 | $172.1M | 44.59% |
| FY2021 | $119.0M | 90.05% |
| FY2020 | $62.6M | (6.83%) |
| FY2019 | $67.2M | 105.11% |
| FY2018 | $32.8M | 87.78% |
| FY2017 | $17.5M | 132.03% |
| FY2016 | $7.5M | (50.04%) |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $43.1M | 31.54% |
| Jun 2026 | $32.8M | 15.80% |
| Mar 2026 | $28.3M | 10.08% |
| Dec 2025 | $25.7M | (46.56%) |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| BAX Baxter International Inc. compare | $1.6B |
| COO The Cooper Companies, Inc. compare | $1.0B |
| ALGN Align Technology, Inc. compare | $749.9M |
| AVTR Avantor, Inc. compare | $584.7M |
| ATR AptarGroup, Inc. compare | $573.5M |
| BLCO Bausch + Lomb Corporation compare | $554.0M |
| SOLV Solventum Corporation compare | $310.0M |
| RGEN Repligen Corporation | $129.9M |
| TFX Teleflex Incorporated compare | $129.3M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on RGEN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement